Regulation of fusion activity by the cytoplasmic domain of a paramyxovirus F protein

Virology

Volumn 301, Issue 2, 2002, Pages 322-333

  Tong, S ^a   Li, M ^a   Vincent, A ^a   Compans, R W ^a   Fritsch, E ^b   Beier, R ^b   Klenk, C ^b   Ohuchi, M ^b   Klenk, H D ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; HN PROTEIN; POLYPEPTIDE; PROTEIN F; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL LABELING; CELL STRAIN; CELL STRAIN BHK; CHANNEL GATING; CONTROLLED STUDY; CYTOPLASM; ERYTHROCYTE; FLUORESCENCE; GENE SEQUENCE; HUMAN; HUMAN CELL; MEMBRANE FUSION; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; REGULATORY MECHANISM; SEQUENCE ANALYSIS; SEROLOGY; SWINE; SYNCYTIUM; VIRION; VIRUS ISOLATION;

PARAMYXOVIRIDAE; RUBULAVIRUS;

EID: 0036400002     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1594     Document Type: Article

References (55)

1. Alkhatib, G., Richardson, C., and Shen S. H. (1990). Intracellular processing, glycosylation, and cell-surface expression of the measles virus fusion protein (F) encoded by a recombinant adenovirus. Virology 175, 262-270.
2. Baker, K. A., Dutch, R. E., Lamb, R. A., and Jardetzky, T. S. (1999). Structural basis for paramyxovirus-mediated membrane fusion. Mol. Cell 3, 309-319.
3. Bousse, T., Takimoto, T., Gorman, W. L., Takahashi, T., and Portner, A. (1994). Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type 1 and Sendai virus important for membrane fusion. Virology 204, 506-514.
4. Cattaneo, R., and Rose, J. K. (1993). Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J. Virol. 67, 1493-1502.
5. Crennell, S., Takimoto, T., Portner, A., and Taylor, G. (2000). Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat. Struct. Biol. 7, 1068-1074.
6. Dutch, R. E., Hagglund, R. N., Nagel, M. A., Paterson, R. G., and Lamb, R. A. (2001). Paramyxovirus fusion (F) protein: A conformational change on cleavage activation. Virology 281, 138-150.
7. Dutch, R. E., and Lamb, R. A. (2001). Deletion of the cytoplasmic tail of the fusion protein of the paramyxovirus simian virus 5 affects fusion pore enlargement. J. Virol. 75, 5363-5369.
8. Dutch, R. E., Leser, G. P., and Lamb, R. A. (1999). Paramyxovirus fusion protein: Characterization of the core trimer, a rod-shaped complex with helices in anti-parallel orientation. Virology 254, 147-159.
9. Fischer, C., Schroth-Diez, B., Herrmann, A., Garten, W., and Klenk, H.-D. (1998). Acylation of the influenza hemagglutinin modulates fusion activity. Virology 248, 284-294.
10. Fuerst, T. R., Earl, P. L., and Moss, B. (1987). Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Mol. Cell Biol. 7, 2538.
11. Fuerst, T. R., Niles, E. G., Studier, F. W., and Moss, B. (1986). Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83, 8122-8126.
12. Green, N., Shinnick, T. M., Witte, O., Ponticelli, A., Sutcliffe, J. G., and Lerner, R. A. (1981). Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc. Natl. Acad. Sci. USA 78, 6023-6027.
13. Heinen, E., Herbst, W., and Schmeer, N. (1998). Isolation of a cytopatho-genic virus from a case of porcine reproductive and respiratory syndrome (PRRS) and its characterization as parainfluenza virus type 2. Arch. Virol. 143, 2233-2239.
14. Heminway, B. R., Yu, Y., and Galinsky, M. S. (1994). Paramyxovirus mediated cell fusion requires co-expression of both the fusion and hemagglutinin-neuraminidase glycoproteins. Virus. Res. 31, 1-16.
15. Hiebert, S. W., Paterson, R. G., and Lamb, R. A. (1985). Hemagglutinin-neuraminidase protein of the paramyxovirus simian virus 5: Nucleotide sequence of the mRNA predicts an N-terminal membrane anchor. J. Virol. 54, 1-6.
16. Holmes, K. V., and Choppin, P. W. (1966). On the role of the response of the cell membrane in determining virus virulence: Contrasting effects of the parainfluenza virus SV5 in two cell types. J. Exp. Med. 124, 501-520.
17. Homma, M., and Ohuchi, M. (1973). Trypsin action on the growth of Sendai virus in tissue culture cells. III. Structural differences of Sendai viruses grown in eggs and tissue culture cells. J. Virol. 12, 1457-1463.
18. Horvath, C. M., Paterson, R. G., Shaughnessy, M. A., Wood, R., and Lamb, R. A. (1992). Biological activity of paramyxovirus fusion proteins: Factors influencing formation of syncytia. J. Virol. 66, 4564-4569.
19. Hsu, M.-C., Scheid, A., and Choppin, P. W. (1981). Activation of the Sendai virus fusion protein (F) involved a conformational change with exposure of a new hydrophobic region. J. Biol. Chem. 256, 3557-3563.
20. Hu, X., Ray, R., and Compans, R. W. (1992). Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J. Virol. 66, 1528-1535.
21. Hull, R. N., Minner, J. R., and Smith, J. W. (1956). New viral agents recovered from tissue cultures of monkey kidney cells. Am. J. Hyg. 63, 204-215.
22. Ito, M., Nishio, M., Komada, H., Ito, Y., and Tsurudome, M. (2000). An amino acid in the heptad repeat 1 domain is important for the haemagglutinin-neuraminidase-independent fusing activity of simian virus 5 fusion protein. J. Gen. Virol. 81, 719-727.
23. Januszeski, M. M., Cannon, P. M., Chen, D., Rozenberg, Y., and Anderson, W. F. (1997). Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J. Virol. 71, 3613-3619.
24. Joshi, S. B., Dutch, R. E., and Lamb, R. A. (1998). A core trimer of the paramyxovirus fusion protein: Parallels to influenza virus hemagglutinin and HIV-1 gp41. Virology 248, 20-34.
25. Karron, R. A., Buonagurio, D. A., Georgiu, A. F., Whitehead, S. S., Adamus, J. E., Clements-Mann, M. L., Harris, D. O., Randolph, V. B., Udem, S. A., Murphy, B. R., and Sidhu, M. S. (1997). Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc. Natl. Acad. Sci. USA 94, 13961-13966.
26. Kohama, T., Garten, W., and Klenk, H.-D. (1981). Changes in conformation and charge paralleling proteolytic activation of Newcastle disease virus glycoproteins. Virology 111, 364-376.
27. LeBivic, A., Quaroni, A., Nichols, B., and Rodriguez-Boulan, E. (1990). Biogenic pathways of plasma membrane proteins in Caco-2, a human intestinal epithelial cell line. J. Cell. Biol. 111, 1351-1361.
28. Li, M., Yang, C., and Compans, R. W. (2001). Mutations in the cytoplasmic tail of MuLV envelope protein suppress fusion inhibition by R peptide. J. Virol 75, 2337-2344.
29. Malvoisin, E., and Wild, T. F. (1993). Measles virus glycoproteins: Studies on the structure and interaction of the hemagglutinin and fusion proteins. J. Gen. Virol. 74, 2365-2372.
30. Matthews, J. M., Young, T. F., Tucker, S. P., and Mackay, J. P. (2000). The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil. J. Virol. 74, 5911-5920.
31. Moreno-Lopez, J., Correa-Giron, P., Martinez, A., and Ericsson, A. (1986). Characterization of a paramyxovirus isolated from the brain of a piglet in Mexico. Arch. Virol. 91(3-4), 221-231.
32. Mulligan, M. J., Yamshchikov, G. V., Ritter, G. D., Gao, F., Jin, M. J., Nail, C. D., Spies, C. P., Hahn, B. H., and Compans, R. W. (1992). Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types. J. Virol. 66, 3971-3975.
33. Nagai, Y., Klenk, H. D., and Rott, R. (1976). Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72, 494-508.
34. Ohuchi, M., Fischer, C., Ohuchi, R., Herwig, A., and Klenk, H.-D. (1998). Elongation of the cytoplasmic tail interferes with the fusion activity of influenza virus hemagglutinin. J. Virol 72, 3554-3559.
35. Paterson, R. G., Harris, T. J., and Lamb, R. A. (1984). Fusion protein of the paramyxovirus simian virus 5: Nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc. Natl. Acad. Sci. USA 81, 6706-6710.
36. Paterson, R. G., Russell, C. J., and Lamb, R. A. (2000). Fusion protein of the paramyxovirus SV5: Destabilizing and stabilizing mutants of fusion activation. Virology 270, 17-30.
37. Ragheb, J. A., and Anderson, W. F. (1994a). pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: Implications for the role of the R peptide and p12E TM in viral entry. J. Virol. 68, 3220-3231.
38. Ragheb, J. A., and Anderson, W. F. (1994b). Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: A functional analysis of the role of TM domains in viral entry. J. Virol. 68, 3207-3219.
39. Randall, R. E., Young, D. F., Goswami, K. K. A., and Russell, W. C. (1987). Isolation and characterization of monoclonal antibodies to SV5 and their use in revealing antigenic differences between human, canine and simian isolates. J. Gen. Virol. 68, 2769-2780.
40. Rein, A., Mirro, J., Gordon-Haynes, J. A., Ernst, S. M., and Nagashima, K. (1994). Function of the cytoplasmic domain of a retroviral transmem-brane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 68, 1773-1781.
41. Rice, N. R., Henderson, L. E., Sowder, R. C., Copeland, T. D., Oroszlan, S., and Edwards, J. F. (1990). Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus. J. Virol. 64, 3770-3778.
42. Ritter, G. D., Mulligan, M. J., Lydy, S. L., and Compans, R. W. (1993). Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain. Virology 197, 255-264.
43. Russell, R., Paterson, R., and Lamb, R. A. (1994). Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein. Virology 199, 160-168.
44. Scheid, A., and Choppin, P. W. (1974). Identification and biological activities of paramyxovirus glycoproteins: Activation of cell fusion, hemolysis, and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology 57, 475-490.
45. Sergel, T., and Morrison, T. G. (1995). Mutations in the cytoplasmic domain of the fusion glycoprotein of Newcastle disease virus depress syncytia formation. Virology 210, 264-272.
46. Sheshberadaran, H., and Lamb, R. A. (1990). Sequence characterization of the membrane protein gene of paramyxovirus simian virus 5. Virology 176, 234-243.
47. Skehel, J. J., and Wiley, D. C. (2000). Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu. Rev. Biochem. 69, 531-569.
48. Sommerfelt, M. A., Petteway, J. S. R., Dreyer, G. B., and Hunter, E. (1992). Effect of retroviral proteinase inhibitors on Mason-Pfizer monkey virus maturation and transmembrane glycoprotein cleavage. J. Virol. 66, 4220-4227.
49. Spies, C. P., Ritter, G. D., Jr., Mulligan, M. J., and Compans, R. W. (1994). Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters conformation of the external domain. J. Virol. 68, 585-591.
50. Takimoto, T., Laver, W. G., Murti, K. G., and Portner, A. (1992). Crystallization of biologically active hemagglutinin-neuraminidase glycoprotein dimers proteolytically cleaved from human parainfluenza virus type 1. J. Virol. 66, 7597-7600.
51. Tsurudome, M., Ito, M., Nishio, M., Kawano, M., Komada, H., Ito, Y. (2001). Hemagglutinin-neuraminidase-independent fusion activity of simian virus 5 fusion (F) protein: Difference in conformation between fusogenic and nonfusogenic F proteins on the cell surface. J. Virol. 75, 8999-9009.
52. Tsurudome, M., Oki, N., Higuchi, Y., Miyahara, K., Yoshimoto, M., Mutsuga, N., Kitada, S., Ogawa, M., Miyahara, Y., Okamoto, K., et al. (1991). Molecular relationships between human parainfluenza virus type 2, and simian viruses 41 and 5: Determination of nucleoprotein gene sequences of simian viruses 41 and 5. J. Gen. Virol. 72, 2289-2292.
53. Yang, C., and Compans, R. W. (1996). Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: Inhibitory effects of the R peptide. J. Virol. 70, 248-254.
54. Yao, Q., and Compans, R. W. (1995). Differences in the role of the cytoplasmic domain of human parainfluenza virus fusion proteins. J. Virol. 69, 7045-7053.
55. Yao, Q., and Compans, R. W. (1996). Peptides corresponding to the heptad repeat sequences of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology 223, 103-112.